indicate that PRV VP16 does not specifically bind to the PRV gH tail. Conclusion: Our results highlight that, despite the relatively close evolutionary relationship between HSV and PRV, there are significant differences in their protein interactions that drive envelopment.
known as the tegument, which is made up of at least 15 different viral proteins, although the functions of many of the tegument proteins remain elusive [1] .
Several studies have indicated that viral envelopment and tegumentation occurs at late Golgi or post-Golgi compartments such as TGN and endosomes [2] [3] [4] . However, the molecular details that drive envelopment are still poorly understood. It appears that there is a redundant web of interactions between capsid proteins, tegument and glycoproteins. For example, in HSV, the tegument protein VP16 is known to interact with other tegument proteins such as VP22 [5] and vhs [6, 7] , as well as glycoprotein H (gH) [8, 9] and possibly gD and gB [10] . Additionally, the HSV tegument proteins UL11 and VP22 have been shown to interact with gE [11] . Also, in PRV, the tegument protein VP22 binds to both gM and gE [12] and simultaneous deletion of both glycoproteins is required to abrogate envelopment and prevent incorporation of VP22 into the mature viral particles [13] . In contrast, for HSV, simultaneous deletion of gE, gI, and gD are required in order to appreciably affect viral egress and inhibit viral maturation and envelopment [14] suggesting that the importance of various sets of protein-protein interactions differs between the two viruses.
We have previously demonstrated that in HSV, the tegument protein VP16 (product of the UL48 gene) interacts with the cytoplasmic tail of gH both in vitro and in vivo [8, 9] . In these experiments, HSV VP16 could be specifically recovered from infected cell extracts using a glutathione S-transferase (GST)-gH tail fusion protein. Additionally, in cells transfected with a construct expressing GFP fused to the gH tail, and infected with wild-type HSV, anti-GFP antibodies could be used to coimmunoprecipitate VP16. These experiments also revealed that the interaction between VP16 and the gH carboxy-terminus is temperature-dependent, in that binding only took place at physiological temperature, but not at lower temperatures [8, 9] .
The aim of this project was to determine whether PRV gH interacts with VP16 in a manner analogous to HSV gH. This experiment was prompted by the observation that the sequences of the gH tails of HSV and PRV are significantly different from one another ( fig. 1 a) . We wanted to ascertain whether, despite the low sequence homology, there would nonetheless be a functional similarity between the gH tails of PRV and HSV.
In order to determine whether PRV VP16 and gH interact, a plasmid was generated expressing GST fused to the predicted cytoplasmic tail of PRV gH ( fig. 1 b) using the GST vector pGEX-KG [15] Tail sequence Name dIII restriction sites used in this study. DNA encoding the PRV gH cytoplasmic tail and the amino acid sequence of the tail are shown above the vector backbone. The tail is fused in frame with GST at the Eco RI site and terminates with two in frame stop codons, followed by the addition of a Pst I site for identification purposes prior to the Hin dIII site, as indicated. Sequences required for bacterial growth and antibiotic selection are not shown.
AGAATAGCCCTCGGAGGAGAAGCTGCAGAGC-ATCTTG-3 were synthesized and annealed, which generates a dsDNA fragment with Eco RI and Hin dIII ends, and which encodes the PRV gH cytoplasmic tail followed by two stop codons and a unique Pst I restriction site for identification purpose. Ligation of this fragment with Hin dIII/ Eco RI digested pGEX-KG DNA results in an in-frame fusion of the GST and gH tail coding regions at the Eco RI site ( fig. 1 b) . In order to perform the subsequent PRV VP16-gH tail binding assay described below, it was necessary to generate anti-PRV VP16 polyclonal antisera. Open Biosystems, Inc. synthesized the oligopeptide HLIPRDALNRMFEM corresponding to the 14 C-terminal amino acids of PRV VP16, which is rich in hydrophilic amino acids and has low sequence homology to HSV VP16. The purified synthetic peptide was injected into rabbits and the resulting serum was evaluated for its specificity to PRV VP16 ( fig. 2 a) . Cell lysates and cell cytosol from PRV-infected and -uninfected RK13 cells as well as cell cytosol from HSV-infected and -uninfected COS cells (prepared as described below) were resolved by 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and Western blotted with the anti-PRV VP16 antisera. Results indicate that the antibody specifically recognizes an approximately 53-kDa protein in the PRV-infected samples, equivalent in size to the predicted molecular weight of PRV VP16. The band was not apparent in uninfected or in HSV-infected samples ( fig. 2 a) , nor was it present in Western blots with preimmune serum (data not shown).
To perform the binding assay, plasmids expressing either GST alone, or GST fusion proteins with either PRV or HSV gH tails were transformed into the Escherichia coli strain BL21 Gold (Stratagene) and bacterial extracts were prepared as previously described [9] . The resulting supernatants were incubated with glutathione-Sepharose beads (GE Healthcare), which had been previously washed twice in PBS. Following a 1-hour incubation at 4 ° , the beads were washed twice with buffer 1 (50 m M Tris-HCl pH 7.6, 150 m M NaCl, 0.5% Triton X-100), then twice with buffer 2 (50 m M Tris-HCl pH 7.6, 1.3 M NaCl, 0.5% Triton X-100), then twice again with buffer 1. At this point, both crude bacterial extract as well as bead-bound material were resolved by 12% SDS-PAGE. In figure 2 , Coomassie blue staining (Pierce) shows that fusion proteins of the correct size of approximately 26 kDa were readily appar- ent in the bacterial extracts ( fig. 2 b 'Extracts') and were specifically isolated and purified after incubation of the bacterial extracts with glutathione-Sepharose beads ( fig. 2 b 'Purified') . The washed beads, bearing specifically-bound GST, GST-PRV gH tail or GST-HSV gH tail fusion proteins were then incubated with cytosol prepared from PRVinfected RK13 cells or HSV-infected COS cells as the source of the tegument protein, VP16. The PRV-and HSV-infected cell cytosols were prepared as follows: confluent monolayers of either RK13 or COS cells were infected at an MOI of 10 with PRV (strain K26 GFP) or HSV-1 (strain SC16), respectively. The infected cells were incubated for 16-18 h at 37 ° , and cell cytosol was prepared as previously described [9] . The PRV-and HSVinfected cell cytosols were incubated at various temperatures and times with Sepharose-bound GST fusion proteins. At the end of the incubation period the beads were recovered, washed three times in buffer 1 (see above) and bead-bound and unbound material examined following SDS-PAGE and Western blotting for PRV VP16 or HSV VP16, as previously described [4] . Additionally, binding reactions were resolved by 12% SDS-PAGE and stained with Coomassie brilliant blue to determine that equivalent levels of the GST fusion proteins were present in this experiment (data not shown).
Western blots indicated that regardless of the temperature or length of incubation, PRV VP16 did not specifically bind to the PRV gH tail/GST fusion protein ( fig. 3 a) . As a positive control, we performed the binding assay with HSV gH/VP16 alongside our PRV binding assay. As expected, we found that the HSV gH tail interacts with HSV VP16 at 37 ° but not at 4 ° ( fig. 3 b) , consistent with our previous findings [8, 9] . These results imply that PRV VP16 does not bind to gH under our established conditions.
These experiments were prompted by the observation that the gH tail of HSV and PRV are significantly different from one another ( fig. 1 a) . Our results highlight that despite the relatively close evolutionary relationship between HSV and PRV, each virus utilizes a different set of tegument-glycoprotein tail interactions to mediate the process of envelopment.
Current studies are focused on identifying tegument binding partners of the cytoplasmic tail of PRV gH. Additionally, new GST fusion constructs are being developed with the cytoplasmic tail of PRV gD as well as other PRV glycoprotein tails to identify other glycoprotein-tegument interactions that may be involved in PRV envelopment. 3 . a Binding of the PRV gH cytoplasmic tail to VP16. GST or GST-PRV gH fusions were induced, bacterial extracts prepared and equivalent amounts of each protein were bound to glutathione-Sepharose beads. These beads were then incubated in duplicate with cytosol prepared from PRV-infected RK13 cells for 1 h at 4 or 37 ° , as indicated. Bound or unbound polypeptides were resolved by 10% SDS-PAGE, transferred to a PVDF membrane, and probed with anti-PRV VP16 antibodies, as indicated. Similar results were obtained with overnight incubations at the respective temperatures. b Binding of the HSV gH cytoplasmic tail to VP16. As a positive control, GST or GST-HSV gH fusions were induced, bacterial extracts prepared and equivalent amounts of each protein were bound to glutathione-Sepharose beads. These beads were then incubated in duplicate with cytosol prepared from HSV-infected COS cells for 1 h at 4 or 37 ° , as indicated. Bound or unbound polypeptides were resolved by 10% SDS-PAGE, transferred to a PVDF membrane, and probed with anti-HSV VP16 antibodies, as indicated.
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